Roman Butler Fullerton & Co’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,710	Closed	-$404K	–	262
2024 Q2	$404K	Buy	+2,710	New	+$404K	0.13%	155